当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析 - 资产负债表

瑞普生物

(300119)

  

流通市值:72.52亿  总市值:100.62亿
流通股本:3.35亿   总股本:4.65亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金532,964,024.05451,404,509.87487,366,788.05347,965,744.03
  交易性金融资产1,326,172,881.781,468,033,933.151,451,255,182.591,342,419,230.18
  应收票据及应收账款1,100,972,432.971,115,237,832.891,070,218,782.151,068,442,700.92
  其中:应收票据23,624,351.0811,097,244.1530,429,747.6935,690,521.7
        应收账款1,077,348,081.891,104,140,588.741,039,789,034.461,032,752,179.22
  应收款项融资14,935,076.4412,267,033.567,522,354.591,871,292.15
  预付款项108,822,448.5587,343,417.9761,196,517.943,369,078.33
  其他应收款合计72,919,033.2367,049,332.0360,184,615.4165,781,801.36
  其中:应收利息--1,055,138.87964,416.66
  存货532,354,914.76511,261,875.85499,573,319.96390,213,709.48
  其他流动资产11,961,526.0412,860,194.3411,651,981.9388,308,108.54
  流动资产合计3,701,102,337.823,725,458,129.663,648,969,542.583,348,371,664.99
非流动资产:
  长期应收款1,955,408.771,336,892.121,455,756.02-
  长期股权投资1,098,769,083.341,093,106,799.381,068,859,364.7457,374,613.02
  其他非流动金融资产66,263,636.26116,644,534.04100,368,039.13626,771,869.94
  投资性房地产35,466,666.2236,464,893.2737,463,120.3538,461,347.41
  固定资产1,783,072,833.151,808,249,950.521,845,590,552.431,810,808,671.14
  在建工程64,431,375.7475,275,598.5362,690,187.68101,693,464.75
  使用权资产13,227,765.1815,038,380.0617,371,440.4212,505,151.49
  无形资产474,453,435.94485,690,665.29493,138,512.76497,418,936.32
  开发支出201,691,230.81197,421,816.35192,998,232.44181,978,059.49
  商誉443,364,365.47443,364,365.47442,263,365.47312,238,524.11
  长期待摊费用1,188,024.251,000,398.55944,104.11329,685.76
  递延所得税资产29,923,471.6227,955,377.5726,948,735.0122,450,744.22
  其他非流动资产40,071,235.4435,337,389.926,732,100.7725,381,877.26
  非流动资产合计4,253,878,532.194,336,887,061.054,316,823,511.294,087,412,944.91
  资产总计7,954,980,870.018,062,345,190.717,965,793,053.877,435,784,609.9
流动负债:
  短期借款883,745,457.48735,362,949.66800,781,866.94688,293,806.34
  应付票据及应付账款514,862,401.23641,048,294.4550,239,664.56472,272,042.63
  其中:应付票据197,445,747.08284,209,449.39187,368,279.18120,580,395.2
        应付账款317,416,654.15356,838,845.01362,871,385.38351,691,647.43
  预收款项8,099,700.67,177,492.078,316,964.05124,256.04
  合同负债42,368,244.1538,211,941.548,111,143.4536,367,202.67
  应付职工薪酬37,523,741.0939,257,793.2567,194,592.4931,107,277.12
  应交税费35,976,619.725,070,276.4224,556,844.8137,107,803.15
  其他应付款合计393,285,010.4578,368,358.71660,575,397.75405,047,346.52
        应付股利23,303,105.8130,806,489.2523,905,106.1935,727,106.19
  一年内到期的非流动负债64,855,107.0360,417,538.7361,077,080.9836,927,605.14
  其他流动负债18,422,113.3913,297,401.129,975,299.3834,058,827.79
  流动负债合计1,999,138,395.072,138,212,045.842,250,828,854.411,741,306,167.4
非流动负债:
  长期借款667,125,639.36643,110,206.4513,813,058.96548,818,610.41
  租赁负债6,303,813.315,647,751.25,247,839.55717,811.51
  递延收益59,793,790.3960,907,071.5663,132,905.461,909,605.66
  递延所得税负债131,744,993.92130,931,204.25125,810,337.7125,184,738.09
  非流动负债合计864,968,236.98840,596,233.41708,004,141.61736,630,765.67
  负债合计2,864,106,632.052,978,808,279.252,958,832,996.022,477,936,933.07
所有者权益(或股东权益):
  实收资本(或股本)464,754,706465,847,906465,847,906465,847,906
  资本公积2,147,521,313.522,157,087,494.682,157,087,494.682,190,777,091.49
  减:库存股191,211,941.65191,871,797.65171,875,332.6571,887,282.66
  盈余公积232,923,953232,923,953232,923,953232,291,974.82
  未分配利润1,907,905,976.141,901,990,815.321,786,006,157.361,732,853,419.99
  归属于母公司股东权益合计4,561,894,007.014,565,978,371.354,469,990,178.394,549,883,109.64
  少数股东权益528,980,230.95517,558,540.11536,969,879.46407,964,567.19
  股东权益合计5,090,874,237.965,083,536,911.465,006,960,057.854,957,847,676.83
  负债和股东权益合计7,954,980,870.018,062,345,190.717,965,793,053.877,435,784,609.9
公告日期2025-08-262025-04-262025-04-032024-10-30
审计意见(境内)标准无保留意见
TOP↑